Healthcare Times Guadeloupe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Guadeloupe.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 26, 2026

Mar. 26, 2026

Humacyte Appoints Rick McElheny as Senior Vice President of Business Development

GlobeNewswire

Mar. 26, 2026

MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results

GlobeNewswire

Mar. 26, 2026

Firefly Confirms Public-Private Partnership with the Department of War

GlobeNewswire

Mar. 26, 2026

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

GlobeNewswire

Mar. 26, 2026

Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update

GlobeNewswire

Mar. 26, 2026

Avicanna Subsidiary SMGH Completes First Commercial Export to Australia

GlobeNewswire

Mar. 26, 2026

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

GlobeNewswire

Mar. 26, 2026

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

GlobeNewswire

Mar. 26, 2026

Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update

GlobeNewswire

Mar. 26, 2026

Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors

GlobeNewswire

Mar. 26, 2026

Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis

GlobeNewswire

Mar. 26, 2026

Preliminary results for the year ended 31 December 2025

GlobeNewswire

Mar. 26, 2026

Sironax Appoints Clive Wang to Board of Directors

GlobeNewswire

Mar. 26, 2026

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

GlobeNewswire

Mar. 26, 2026

Tilray Brands Announces Partnership with Popsicle® to Launch Popsicle Adult Beverages

GlobeNewswire

Mar. 26, 2026

Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team

GlobeNewswire

Mar. 26, 2026

Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer

GlobeNewswire

Mar. 26, 2026

MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 26, 2026

Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit

GlobeNewswire

Mar. 26, 2026

Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain

GlobeNewswire